BBIO•benzinga•
BridgeBio To Share Cardiovascular Outcomes Data In Patients With Variant And Wild-type ATTR-CM From ATTRibute-CM, Its Phase 3 Study Of Acoramidis In ATTR-CM
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 24, 2025 by benzinga